A detailed history of Phraction Management LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Phraction Management LLC holds 47,021 shares of BDX stock, worth $11.5 Million. This represents 4.12% of its overall portfolio holdings.

Number of Shares
47,021
Previous 43,883 7.15%
Holding current value
$11.5 Million
Previous $10.6 Million 0.82%
% of portfolio
4.12%
Previous 4.11%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$220.02 - $243.75 $690,422 - $764,887
3,138 Added 7.15%
47,021 $10.7 Million
Q3 2024

Nov 06, 2024

BUY
$221.47 - $242.41 $282,595 - $309,315
1,276 Added 2.99%
43,883 $10.6 Million
Q2 2024

Aug 01, 2024

BUY
$225.07 - $246.17 $1.22 Million - $1.34 Million
5,426 Added 14.59%
42,607 $9.96 Million
Q1 2024

May 13, 2024

BUY
$233.45 - $247.73 $993,796 - $1.05 Million
4,257 Added 12.93%
37,181 $9.2 Million
Q4 2023

Feb 05, 2024

BUY
$232.24 - $267.23 $1.67 Million - $1.92 Million
7,183 Added 27.9%
32,924 $8.03 Million
Q3 2023

Nov 08, 2023

SELL
$254.9 - $283.59 $164,920 - $183,482
-647 Reduced 2.45%
25,741 $6.65 Million
Q2 2023

Aug 03, 2023

SELL
$238.39 - $265.32 $77,953 - $86,759
-327 Reduced 1.22%
26,388 $6.97 Million
Q1 2023

Apr 28, 2023

BUY
$229.71 - $259.35 $1.17 Million - $1.32 Million
5,077 Added 23.46%
26,715 $6.61 Million
Q4 2022

Feb 07, 2023

BUY
$218.29 - $256.91 $1.36 Million - $1.6 Million
6,245 Added 40.57%
21,638 $5.5 Million
Q3 2022

Nov 02, 2022

SELL
$51.03 - $264.23 $108,949 - $564,131
-2,135 Reduced 12.18%
15,393 $3.43 Million
Q2 2022

Aug 08, 2022

BUY
$234.74 - $275.42 $133,801 - $156,989
570 Added 3.36%
17,528 $4.32 Million
Q4 2021

Feb 03, 2022

BUY
$230.08 - $250.94 $3.9 Million - $4.26 Million
16,958 New
16,958 $4.27 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $69.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Phraction Management LLC Portfolio

Follow Phraction Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phraction Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Phraction Management LLC with notifications on news.